#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA4222639	Binding	Inhibition of wild type HIV1 reverse transcriptase using poly (A)/oligo (dT)15 as template/primer assessed as decrease in biotin-dUTP incorporation after 1 hr by ELISA	Human immunodeficiency virus 1	22	ALA4219160	single protein format	Scientific Literature
2.	ALA4222640	Functional	Antiviral activity against wild type HIV1 3B infected in human MT4 cells assessed as protection against virus-induced cytopathic effect after 5 days by MTT assay	Human immunodeficiency virus 1	23	ALA4219160	organism-based format	Scientific Literature
3.	ALA4222641	Functional	Antiviral activity against HIV2 ROD infected in human MT4 cells assessed as protection against virus-induced cytopathic effect after 5 days by MTT assay	Human immunodeficiency virus 2	20	ALA4219160	organism-based format	Scientific Literature
4.	ALA4222642	ADME	Cytotoxicity against human MT4 cells assessed as reduction in cell viability after 5 days by MTT assay	Homo sapiens	23	ALA4219160	cell-based format	Scientific Literature
5.	ALA4222643	Toxicity	Selectivity index, ratio of CC50 for human MT4 cells to EC50 for wild type HIV1 3B infected in human MT4 cells		23	ALA4219160	cell-based format	Scientific Literature
6.	ALA4222644	Functional	Antiviral activity against HIV1 harboring reverse transcriptase L100I mutant infected in human MT4 cells assessed as protection against virus-induced cytopathic effect after 5 days by MTT assay	Human immunodeficiency virus 1	23	ALA4219160	organism-based format	Scientific Literature
7.	ALA4222645	Functional	Antiviral activity against HIV1 harboring reverse transcriptase K103N mutant infected in human MT4 cells assessed as protection against virus-induced cytopathic effect after 5 days by MTT assay	Human immunodeficiency virus 1	23	ALA4219160	organism-based format	Scientific Literature
8.	ALA4222646	Functional	Antiviral activity against HIV1 harboring reverse transcriptase Y181C mutant infected in human MT4 cells assessed as protection against virus-induced cytopathic effect after 5 days by MTT assay	Human immunodeficiency virus 1	22	ALA4219160	organism-based format	Scientific Literature
9.	ALA4222647	Functional	Antiviral activity against HIV1 harboring reverse transcriptase Y188L mutant infected in human MT4 cells assessed as protection against virus-induced cytopathic effect after 5 days by MTT assay	Human immunodeficiency virus 1	22	ALA4219160	organism-based format	Scientific Literature
10.	ALA4222648	Functional	Antiviral activity against HIV1 harboring reverse transcriptase E138K mutant infected in human MT4 cells assessed as protection against virus-induced cytopathic effect after 5 days by MTT assay	Human immunodeficiency virus 1	23	ALA4219160	organism-based format	Scientific Literature
11.	ALA4222649	Functional	Antiviral activity against HIV1 harboring reverse transcriptase F227L/V106A double mutant infected in human MT4 cells assessed as protection against virus-induced cytopathic effect after 5 days by MTT assay	Human immunodeficiency virus 1	22	ALA4219160	organism-based format	Scientific Literature
12.	ALA4222650	Functional	Antiviral activity against HIV1 harboring reverse transcriptase RES056 double mutant infected in human MT4 cells assessed as protection against virus-induced cytopathic effect after 5 days by MTT assay	Human immunodeficiency virus 1	23	ALA4219160	organism-based format	Scientific Literature
13.	ALA4222651	Binding	Inhibition of HIV1 reverse transcriptase K103N/Y181C double mutant using poly (A)/oligo (dT)15 as template/primer assessed as decrease in biotin-dUTP incorporation after 1 hr by ELISA	Human immunodeficiency virus 1	20	ALA4219160	single protein format	Scientific Literature